| _version_ |
1819012467719667712
|
| collection |
DOAJ
|
| first_indexed |
2024-12-21T01:44:31Z
|
| format |
Article
|
| id |
doaj.art-98b49330b88e4cb3a30a40500467de37
|
| institution |
Directory Open Access Journal
|
| issn |
2051-1426
|
| language |
English
|
| last_indexed |
2024-12-21T01:44:31Z
|
| publishDate |
2021-10-01
|
| publisher |
BMJ Publishing Group
|
| record_format |
Article
|
| series |
Journal for ImmunoTherapy of Cancer
|
| spelling |
doaj.art-98b49330b88e4cb3a30a40500467de372022-12-21T19:20:03ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-10-0191010.1136/jitc-2020-001701corr1Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germanyhttps://jitc.bmj.com/content/9/10/e001701corr1.full
|
| spellingShingle |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
Journal for ImmunoTherapy of Cancer
|
| title |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
|
| title_full |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
|
| title_fullStr |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
|
| title_full_unstemmed |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
|
| title_short |
Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
|
| title_sort |
correction real life use of talimogene laherparepvec t vec in melanoma patients in centers in austria switzerland and germany
|
| url |
https://jitc.bmj.com/content/9/10/e001701corr1.full
|